GreenTech, DARPA, Clinical Trials Corey Hubbard GreenTech, DARPA, Clinical Trials Corey Hubbard

Building a Greener Future: How AI and Smart Tech are Making Biofabrication Sustainable

Imagine a world where we can grow human tissues for transplants, create new materials from living cells, and even develop bio-robots, all while being kind to our planet. This vision is at the heart of biofabrication, a fascinating and rapidly evolving field that blends biology, materials science, medicine

Read More
Digital Innovation, DARPA, Algorithms, Nvidia Corey Hubbard Digital Innovation, DARPA, Algorithms, Nvidia Corey Hubbard

Artificial Intelligence Unleashed: Navigating the Global Impact and Future Landscape

Artificial Intelligence (AI) is no longer a concept confined to science fiction; it is a transformative technology deeply woven into the fabric of our daily lives, fundamentally altering how we interact with the world around us. Defined as an academic discipline focused on developing computer systems and robots that possess human-like intelligence, including cognitive powers

Read More

AI-Designed Oral GLP-1RA Shows Promise in Weight Loss

In the ongoing global health challenge of obesity and its associated conditions, the search for effective and convenient treatments is paramount. Recently, a significant breakthrough has emerged from China-based MindRank, a biotech company that has reported promising results from its Phase IIb clinical trial for an oral medication known as MDR-001.

Read More
Algorithms, Technology, Digital Age Corey Hubbard Algorithms, Technology, Digital Age Corey Hubbard

The concept of "fairness" in algorithms is a complex and increasingly critical topic

At its core, an algorithm is a set of rules or instructions that a computer follows to perform a task or solve a problem. In the context of AI, these algorithms often "learn" from vast amounts of data to make predictions or decisions. For example, a machine learning algorithm might be trained on historical loan application data to decide who qualifies for a loan

Read More
Technology, Clinical Trials, Health Equity Corey Hubbard Technology, Clinical Trials, Health Equity Corey Hubbard

The Dawn of Autonomous Science: Lila Sciences and the Future of Bioform Innovation

The bioplatform innovation company Flagship Pioneering unveiled Lila Sciences, marking a significant stride into the era of autonomous science. Lila Sciences aims to revolutionize scientific exploration by introducing Autonomous Science to the physical world, a concept that combines artificial intelligence (AI), robotics, and automated laboratories.

Read More
Technology, Clinical Trials, Insomnia Corey Hubbard Technology, Clinical Trials, Insomnia Corey Hubbard

The Sandman's New Assistant: AI and the Quest for Better Sleep

Sleep. That elusive, restorative state that we all crave, yet so many struggle to achieve. In our fast-paced, tech-driven world, a good night's rest often feels like a luxury, not a necessity. But what if technology, the very thing that sometimes keeps us up, could also be the key to unlocking better sleep? Enter artificial intelligence (AI), the potential game-changer in our quest for a peaceful slumber.

Read More
Energy, Technology, Research Corey Hubbard Energy, Technology, Research Corey Hubbard

The Algorithmic Spark: How AI is Revolutionizing Electrolyte Design for a Sustainable Future

Adverse climate change, the undeniable reality of global warming, and the pressing need for energy security have converged to present humanity with some of its most formidable challenges. At the heart of these challenges lies the need for sustainable energy solutions, and central to these solutions is the development of high-performance battery technologies. These technologies, essential for electric vehicles, renewable energy storage, and countless other applications, hinge on the intricate chemistry of their components, with electrolytes playing a particularly critical role. Traditionally, electrolyte discovery has been a slow, iterative, and often frustrating process, reliant on trial and error. However, the burgeoning field of artificial intelligence (AI) offers a potential paradigm shift, promising to accelerate the design of novel electrolytes and usher in a new era of battery innovation.

Read More
AI/ML, Healthcare, Health Equity, Drug Research Corey Hubbard AI/ML, Healthcare, Health Equity, Drug Research Corey Hubbard

How Artificial Intelligence is Reshaping Drug Target Identification

In the labyrinthine world of pharmaceutical research, the quest for effective new drugs often resembles a painstaking expedition through an uncharted wilderness. The initial and perhaps most critical phase of this journey is the identification of viable drug targets—specific molecules within the body that play a pivotal role in a disease's progression and can be modulated by therapeutic interventions. Traditionally, this process has been slow, expensive, and fraught with uncertainty. However, a revolutionary force is now transforming this landscape: Artificial Intelligence (AI). By harnessing the power of vast datasets and sophisticated algorithms, AI is rapidly reshaping the field of drug target identification, offering unprecedented speed, precision, and potential.

Read More
Psycholgoy, Research, ML, Allison Elias Corey Hubbard Psycholgoy, Research, ML, Allison Elias Corey Hubbard

Digital Footprints and Machine Learning in Psychological Assessment: Challenges and Ethical Implications

The integration of technology into various facets of modern life has ushered in a new era in the field of psychological assessment. With the advent of smartphones, wearables, and social media platforms, vast amounts of digital data are being generated, creating "digital footprints." These digital traces, coupled with the analytical power of machine learning, are fundamentally transforming how psychological states are evaluated. This essay explores the potential benefits and drawbacks of leveraging digital footprints and machine learning in psychological assessment, focusing on the inherent challenges and ethical implications.

Read More